![]() |
|
|
Vol. 283, Issue 2, 770-777, 1997
Department of Pharmacology, Akita University School of Medicine, Akita 010, Japan
| |
Abstract |
|---|
|
|
|---|
In the present study, we have investigated the mechanism underlying the
activation by
5-amino-N-[2-(2-chlorophenyl)ethyl]-N
-cyano-3-pyridinecarboxamidine (KRN4884), a new K+ channel opener, of ATP-sensitive
K+ (KATP) channels in single ventricular cells
of guinea pig hearts by the inside-out patch-clamp method. In the
presence of intracellular ATP (1 mM), KRN4884 (0.1-3 µM) activated
KATP channels in a concentration-dependent manner
(EC50 = 0.55 µM) without affecting the unitary current conductance and the gating properties. KRN4884 (0.3 µM) shifted the
concentration-response relationship for ATP-induced KATP
channel inhibition to the right and slightly upward direction without altering the slope. After either the spontaneous or
Ca++-induced channel rundown, KRN4884 (1 and 3 µM)
partially restored the KATP channel activity. Furthermore,
the effect of KRN4884 was augmented by the presence of uridine
5
-diphosphate (3 mM). The results indicate that KRN4884 activates
cardiac KATP channels through not only decreasing the
sensitivity of the channel to ATP but also directly stimulating the
opening of the channel.
| |
Introduction |
|---|
|
|
|---|
KATP
channels, which are present in various tissues (Noma, 1983
; Cook and
Hales, 1984
; Spruce et al., 1987
; Standen et al., 1989
), play fundamental roles in various physiological and
pathophysiological conditions (Ashcroft and Ashcroft, 1990
; Edwards and
Weston, 1993
). In the cardiovascular system, activation of
KATP channels causes vascular relaxation (Samaha
et al., 1992
), shortening of cardiac action potential
duration and a decrease of contractility (Fosset et al.,
1988
; Nichols et al., 1991
). These effects would be
cardioprotective by prohibiting excessive ATP consumption and
Ca++-overload (Escande and Cavero, 1992
; Lawson
and Downey, 1993
; Grover, 1994
).
Several pharmacological agents, known as K+
channel openers, can activate KATP channels and
therapeutic usage of these drugs has been suggested for cardiovascular
diseases such as hypertension, arrhythmia, angina pectoris, ischemic
heart disease and congestive heart failure (Anderson, 1992
). The
K+ channel openers consist of compounds with
diverse chemical structures. These include pyridine derivatives such as
pinacidil and nicorandil, benzopyran derivative (e.g.,
cromakalim), butenoic acid (e.g., ER001533) and so on
(Edwards and Weston, 1993
). KRN4884 is a novel pyridine derivative
related to nicorandil, and it was recently reported that KRN4884
produced a long-lasting hypotensive effect compared with levcromakalim
in anesthetized dogs (Izumi et al., 1995
). KRN4884 had
greater specificity for the coronary vasculature than
Ca++ channel blockers such as nifedipine and
nilvadipine (Izumi et al., 1995
). We have found potentiation
by nitric oxide of KATP channel current induced
by KRN4884 or cromakalim (Shinbo and Iijima, 1997
). In rat isolated
aorta, the effects of KRN4884 were inhibited by glibenclamide (1 µM)
(Izumi et al, 1995
; Shinbo and Iijima, 1997
). These findings
suggest that activation of KATP channels might be
responsible for the pharmacological effects of KRN4884. However, no
systematic study has been performed regarding the cellular mechanism of
its action.
In the present study, single channel currents were recorded in guinea pig ventricular cells to determine the mechanism of actions of KRN4884. We show that KRN4884 activates cardiac KATP channels both by decreasing the affinity of the channels to ATP and by a mechanism independent of intracellular ATP.
| |
Methods |
|---|
|
|
|---|
Cell preparation.
Single ventricular cells of guinea pig
hearts were obtained by an enzymatic dissociation procedure (Isenberg
and Klöckner, 1982
). Guinea pigs weighing 250 to 590 g were
anesthetized with pentobarbital (50-60 mg/kg i.p.). Under artificial
respiration, the heart was quickly removed from the thorax and hung on
a Langendorff type apparatus to start the coronary perfusion with a
Ca++-free Tyrode's solution. The heart was then
perfused with Ca++-free Tyrode's solution
containing 0.04% (w/v) collagenase (200-230 units/mg; Wako Pure
Chemical Industry, Osaka, Japan) for 25 to 35 min at 35°C. After the
enzyme treatment, the heart was rinsed with a high
K+, low Cl
storage
solution. Then the left ventricle was dissected from the digested
heart, and stored in the storage solution at 4°C for later use.
Solutions and drugs.
The normal Tyrode's solution contained
(in mM): NaCl, 136.9; KCl, 5.4; CaCl2, 1.8;
MgCl2, 0.53;
NaH2PO4, 0.33; HEPES, 5.0; and glucose, 5.5; pH = 7.4, adjusted with NaOH. The high
K+, low Cl
storage
solution contained (in mM): taurine, 10; oxalic acid, 10;
L-glutamic acid, 70; KCl, 25;
KH2PO4, 10; EGTA, 0.5;
glucose, 11; and HEPES, 10; pH = 7.4, adjusted with KOH. The
pipette solution contained (in mM): KCl, 150;
CaCl2, 1; HEPES, 5; pH = 7.4, adjusted with
KOH. The bath solution contained (in mM): KCl, 150;
MgCl2, 0.5; HEPES, 5; EGTA, 1; pH = 7.2, adjusted with KOH. ATP disodium salt (0-10 mM) was added into the bath
solution to give the concentration described in the text. The
concentration of free Mg++ in the bath solution
was kept constant at 0.5 mM.
|
Electrophysiological recordings.
The patch-clamp technique
(Hamill et al, 1981
) was used to record currents from
inside-out membrane patch using a patch-clamp amplifier (Nihon Kohden
CEZ-2300, Tokyo, Japan). Patch pipettes were pulled with a micropipette
puller (model P-97, Sutter Instrument Co., Novato, CA) from glass
capillary tubing (Corning 7052; Warner Instrument Co., CT), and the
electrode resistance was 4 to 10 megaohm. The data were stored on
digital audio tape with a DAT recorder (TEAC, Tokyo, Japan) for later
computer analysis.
Data analysis. The data were low-pass filtered at 1 to 3 kHz, and digitized at 2 to10 kHz into a computer (IBM-compatible 386, Proside, Tokyo, Japan or PC-98, NEC, Tokyo, Japan) with either pClamp software (Axon Instruments, Foster City, CA) or in-house programs made by us. For analyzing the open- and closed-time distributions, the threshold for event detection was set at half of the unitary single channel amplitude. Usually the patch membrane contained more than two active channels, and it was quite difficult to obtain patches with only one active channel. Therefore, the analysis was confined within bursting activity where no overlap of the channel opening was detected, and closed-time more than 30 ms was discarded.
To quantitatively analyze the effect of KRN4884 or other compounds, channel activity was expressed as NPoi, where N is the number of channels in the patch, Po is the open probability of channel and i is the unitary current. NPoi was calculated by integrating a 5- to 15-s continuous current record during the steady effect of each drug. The concentration-response curve for KRN4884 was obtained by normalizing NPoi to that obtained by superfusing with the ATP-free bath solution, and fit to a Hill equation by the least squares method:
|
|
| |
Results |
|---|
|
|
|---|
Activation by KRN4884 of KATP channels in guinea pig ventricular cells. After the gigaohm-seal was established, the bath solution was switched from the normal Tyrode's solution to the high-K+, ATP-free bath solution, and the membrane potential was held at 50 mV. Then the patch membrane was excised in the ATP-free bath solution, resulting in rapid activation of outward channel currents (fig. 1A). The current was inhibited by addition of 1 mM ATP into the bath solution, confirming that the current was caused by the K+ current flowing through KATP channels. KRN4884 (0.3 and 3 µM) increased the outward current in a concentration-dependent manner, and the unitary current amplitudes were similar to that of KATP channels in the ATP-free solution. Furthermore, channel activity was abolished by 3 µM glibenclamide (fig. 1A).
The concentration-response relationship for KRN4884 on cardiac KATP channels was examined in the presence of 1 mM ATP (fig. 1B). NPoi was determined at each concentration of KRN4884 (0.1-3 µM) and normalized to that obtained in the ATP-free bath solution. The curve was fitted with the Hill equation 1 by the least squares method (see "Methods") with an EC50 of 0.55 µM and a Hill coefficient of 1.24.Effects of KRN4884 on the KATP channel
kinetics.
Single-channel properties were compared between the
KATP channel current in the ATP-free bath
solution and the channel current induced by KRN4884 (0.3 µM) in 1 mM
ATP-containing bath solution. As shown in figure
2A, both channel currents were outward at
positive potentials and inward at negative potentials, and reversed at approximately 0 mV. At negative potentials, inwardly rectifying K+ channels with relatively small unitary
amplitude and long opening time overlapped with either
KATP channels (left panels) or KRN4884-induced channels (right panels).
|
60 mV, however,
an additional peak representing the inwardly rectifying
K+ channels was observed. The amplitude
histograms were well fit as the sum of two (60 mV) and three (
60 mV)
Gaussian distributions (fig. 2B). At 60 mV, the unitary current
amplitude was measured as the difference between the two peaks. On the
other hand, at
60 mV, the probability of the inwardly rectifying
K+ channels staying open was very high, and most
openings of KATP channels overlapped with the
opening of the inwardly rectifying K+ channels
(see fig. 2A). Thus, the unitary amplitude was measured as the
difference between the middle (asterisks) and the left peak (arrows) of
the histograms (fig. 2B). The unitary amplitudes in the
KATP channel current were
5.7 ± 0.1 pA
(n = 6) at
60 mV and 3.9 ± 0.1 pA
(n = 8) at 60 mV. These values were not significantly different from those of the KRN4884-induced channel current:
5.8 ± 0.4 pA (n = 6) at
60 mV and 3.6 ± 0.1 pA
(n = 8) at 60 mV. The current-voltage curves for the
KATP channel current and KRN4884-induced channel
current were almost identical (fig. 2C), i.e., they were linear at negative potential and showed inward rectification at positive potential. The reversal potential was close to 0 mV. The slope
conductance at negative potentials was 96.0 pS for the KATP channel current and 94.2 pS for the
KRN4884-induced channel current.
To analyze the open- and closed-time distributions for both the
KATP channel and the channel induced by KRN4884
(0.1 µM) in the presence of ATP (1 mM), the histograms of both
distributions at 60 mV were constructed. Both the open- and closed-time
histograms were well fit with a sum of two exponentials, and
representative examples are shown in figure
3. As for the KATP
channel current, the time constants of the exponential distribution
were 0.76 ± 0.33 and 5.22 ± 1.16 ms for the open-time
histograms, and 0.29 ± 0.02 and 6.45 ± 3.59 ms for the
closed-time histograms (n = 4). These values were not
statistically different from those of the KRN4884-induced channel
current, which were 0.68 ± 0.25 and 3.73 ± 0.49 ms for the
open-time histograms, and 0.23 ± 0.02 and 7.23 ± 1.28 ms
for the closed-time histograms (n = 4). These findings, together with the single channel conductance and the sensitivity to
glibenclamide, confirmed that the channels activated by KRN4884 can be
identified as KATP channels in cardiac myocytes.
|
Effect of KRN4884 on ATP inhibition of KATP
channels.
After confirming the activation of the
KATP channels at 50 mV in the ATP-free bath
solution, ATP (0.01-1 mM) was cumulatively applied. ATP inhibited the
channel current in a concentration-dependent manner (fig.
4A). In the presence of KRN4884 (0.3 µM), the concentration of ATP required to inhibit the channel current
increased (fig. 4B). As shown in figure 4B (expanded time scale), it is
obvious that KRN4884 (0.3 µM) enhanced the KATP
channel current activated in the ATP-free bath solution. Similar
results were obtained in five of six patches.
|
Effects of KRN4884 on KATP channels after
rundown.
After activation of KATP channels
in the ATP-free bath solution, the channel activity spontaneously
declined with time, which is known as rundown (Trube and Hescheler,
1984
). This phenomenon was thought to be caused by dephosphorylation of
the channel (Misler et al., 1986
; Findlay, 1987
) and/or by
depolymerization of actin cytoskeleton (Furukawa et al.,
1996
). It appeared that KRN4884 partially restored the channel activity
after rundown and that this effect largely depended on the extent of
rundown. As demonstrated in figure 5,
KRN4884 was applied to the patch membrane during various degrees of
rundown. When rundown was incomplete (fig. 5A), i.e.,
NPoi decreased to 20% at 1.5 min after the
exposure to ATP-free solution, KRN4884 (3 µM) remarkably increased
the KATP channel activity. On the other hand,
KRN4884 reactivated the KATP channels only
slightly when it was applied after long exposure to ATP-free solution
(fig. 5B). No reactivation was produced by KRN4884 (~10 µM) after
much more prolonged exposure to ATP-free solution (fig. 5C). This was
not caused by loss of the KATP channels during
the course of experiments, because the subsequent application of 5 mM
ATP for 3 min could restore the channel activity (fig. 5C). To
quantitatively analyze this phenomenon, the mean patch current
(NPoi) was measured at the peak response to
ATP-free solution (NPoiPeak), and just before
(NPoiRundown) and during
application of 3 µM KRN4884
(NPoiKRN4884). The extent
of rundown and the reactivation by KRN4884 were quantified as the
ratios
NPoiRundown/NPoiPeak and
NPoiKRN4884/NPoiPeak,
respectively. The data obtained from 19 patches are shown in figure 5D.
A positive correlation is evident (
= 0.907, P < .0001).
|
|
Synergistic effect of intracellular NDP and KRN4884 on
KATP channels after rundown.
The effects
of KRN4884 on KATP channels, described so far,
are similar to those of intracellular NDP. That is, binding of NDPs to
their own receptor on KATP channels not only
stimulates opening of the channels that had been closed by ATP but also
directly activates the channel after rundown (Lederer and Nichols,
1989
; Tung and Kurachi, 1991
). It is thus important to know whether the
effects of NDP and KRN4884 are additive or synergistic. In this
experiment we used UDP because UDP was thought to bind selectively to
the NDP site without affecting the ATP binding site of the channel
(Tung and Kurachi, 1991
). Prolonged exposure to ATP-free solution led
the KATP channel to almost complete rundown. This was confirmed by applying KRN4884 (0.3 µM) without any change of the
channel current (fig. 7). Under this
condition, UDP (3 mM) alone reactivated KATP
channels. Subsequently, the same concentration of KRN4884 (0.3 µM)
clearly facilitated the channels. In figure 7B, the data obtained from
seven cells are summarized. In five patches examined, KRN4884 (0.3 µM) did not increase NPoi in the absence of UDP
but consistently facilitated the openings of the KATP channels in the presence of UDP. On the
average the relative NPOi was 0.437 ± 0.100 for UDP and 0.909 ± 0.184 for UDP plus KRN4884 (P < .01, n = 7). Essentially similar results were obtained with
3 µM KRN4884 (data not shown).
|
| |
Discussion |
|---|
|
|
|---|
In the present experiments, we demonstrated that KRN4884, a new
K+ channel opener, activated cardiac
KATP channels in ventricular cells of the guinea
pig hearts. The unitary conductance of 96 pS (fig. 2C) and the gating
properties (mean open time: approximately 2 ms at 60 mV) (fig. 3) were
almost identical with those of KATP channels
recorded in the ATP-free bath solution. These characteristics correspond to those of KATP channels described so
far in cardiac myocytes (Tung and Kurachi, 1991
; Shen et al,
1992
). The EC50 of KRN4884 (0.55 µM, fig. 1B)
was much smaller than those of pinacidil (65 µM, Arena and Kass,
1989
), cromakalim (>30 µM, A. Shinbo and T. Iijima, unpublished
data), nicorandil (74 µM, Takano and Noma, 1990
), KR-30450 (~10
µM, Kwak et al., 1995
), HOE-234 (~1 µM, Terzic et al., 1994
), but similar to ER-001533 (0.58 µM, Shen
et al., 1992
). Although the EC50 can
be significantly affected by the recording mode and/or intracellular
ATP concentration (Terzic et al., 1994
; Nakayama et
al., 1990
), we may conclude that KRN4884 is one of the potent
KATP channel openers described so far.
At least two different mechanisms should be considered for the
activation of KATP channels by KRN4884: decrease
in the sensitivity of the KATP channel to ATP and
activation of the channel independent of intracellular ATP. The former
effect is characterized by a rightward shift of the ATP
concentration-KATP channel activity relationship
without a significant alteration of the slope (fig. 4C). On the other
hand, the slight upward shift of the relationship (fig. 4C) may suggest
the latter ATP-independent activation of the channel. Furthermore, more
striking evidence for the ATP-independent mechanism is that KRN4884
(
1 µM) reactivated KATP channels after rundown (figs. 5 and 6). It is well known that, after rundown of the
channel, application of Mg-ATP into bath solution could restore the
channel activity (Takano et al, 1990
). Rundown has, therefore, been considered to be associated with dephosphorylation of
the channel (Misler et al., 1986
; Findlay, 1987
) and/or
depolymerization of actin cytoskeleton (Furukawa et al.,
1996
). If so, KRN4884 may activate KATP channels
by producing a conformational change of the channel which is normally
regulated by the ATP-dependent process. The upward shift of the
relationship might be explained by assuming that even immediately after
removing intracellular ATP some KATP channels had
already been in the dephosphorylated state and/or actin cytoskeletons
had been depolymerized.
Findlay (1994)
classified various K+ channel
openers into two categories according to their functional similarities.
Type 1 drugs such as pinacidil and cromakalim possess ATP-dependent and independent activation properties, whereas type 2 drugs, such as
HOE-234, ER-001533 and KR-30450, only decrease the sensitivity of the
channel to ATP. The mode of action of these substances can be
interpreted based on a functional model proposed by Tung and Kurachi
(1991)
, where three different regulatory sites of the channel exist:
the channel gate, the transducer unit and the ATP binding site. The
transducer unit can send the signal to the gate only when it is
phosphorylated or bound with NDP. Under such conditions, the removal of
ATP from the ATP binding site enables the transducer unit to send the
signal to open the gate whereas the binding of ATP closes the gate.
According to this model, type 2 drugs act on the ATP binding site and
antagonize the inhibitory effect of ATP on the channel in a competitive
manner (Shen et al., 1992
; Terzic, et al., 1994
;
Kwak et al., 1995
). On the other hand, type 1 drugs are
supposed to activate the channel by interacting with the transducer
unit where it is either phosphorylated or bound with NDP. In support of
this view, Shen et al. (1991)
showed that pinacidil and
lemakalim activated the channel which was inhibited by ATP before
rundown, and were effective to reactivate the inactivated channel after
rundown only in the presence of NDPs.
In the present study, KRN4884 activated KATP
channels both before and after rundown irrespective of whether NDP was
present or not (figs. 1, 4, 5, 6 and 7). The results might indicate
that KRN4884 acts differently from either type 1 or type 2 drugs.
However, this is not likely. Although KRN4884 reactivated the
KATP channel more or less after rundown, the
potency for reactivating the channel clearly depended on the extent of
rundown, i.e., the reactivation was marked if the channel
activity was still substantial (fig. 5A) but was insignificant against
the little channel activity after prolonged exposure to ATP-free
solution. The finding could be explained by assuming various degrees of
rundown (Fan et al., 1990
). Namely, KRN4884 could reactivate
the channel during the partial rundown but not in the complete rundown.
In this respect, KRN4884 might be classified in type 1 drugs.
Furthermore, even after almost complete rundown where KRN4884 (0.3 µM) failed to activate KATP channels, the
reactivation by KRN4884 was clearly produced in the presence of UDP
(fig. 6). The results suggest that the reactivation by KRN4884 requires
partial phosphorylation of the transducer unit or binding of NDP to its
site, as indicated in pinacidil or lemakalim (Shen et al.,
1991
).
Recent studies have demonstrated that the pancreatic
cell
KATP channel is a heteromultimer composed of at
least two different subunits; KATP-
and
KATP-
(Inagaki et al., 1995
).
KATP-
is the inward rectifier subunit BIR
(Kir6.2) and KATP-
is sulfonylurea receptor
(SUR), a member of the ATP binding cassette superfamily (Aguilar-Bryan
et al., 1995
). Then Inagaki et al. (1996)
cloned an isoform of SUR (SUR2) from the rat brain and demonstrated that SUR2
mRNA was expressed at high levels in heart and skeletal muscle. Furthermore, the ATP sensitivity and pharmacological properties of
KATP channels were determined by a family of
structurally related but functionally distinct sulfonylurea receptors
(Inagaki et al, 1995
, 1996
). It is thus likely that SUR2
represents a functional role of the transducer unit originally assumed
in the functional model by Tung and Kurachi (1991)
. KRN4884 may
interact with SUR2 to activate cardiac KATP
channels.
KRN4884 was originally found to produce a profound hypotensive effect
in anesthetized dogs and to have greater specificity in coronary
arteries (Izumi et al., 1995
). The differences in tissue
affinities, which might be caused by different SUR isoforms, may help
to establish the new therapeutic strategies for various diseases
including hypertension, arrhythmia, congestive heart failure and
ischemic heart disease. However, no data are available now to compare
the activity of KRN4884 between native cardiac and smooth muscle
KATP channels. Recent molecular analysis
indicates that the channel composed of inward rectifier subunit Kir 6.1 (Inagaki et al., 1995
.) and an isoform of SUR (SUR2B,
Isomoto et al., 1996
) resembles the K+
channel found in vascular smooth muscle cells (Yamada et al. 1997
). Future molecular studies are clearly necessary to determine the
tissue specificity as well as the nature of the interaction between the
KATP channel and KRN4884.
| |
Acknowledgments |
|---|
We thank Mr. Fujisawa for excellent technical assistance. We are also grateful for the generous supplies of KRN4884 by Kirin Brewery Co. Ltd., Tokyo, Japan.
| |
Footnotes |
|---|
Accepted for publication July 30, 1997.
Received for publication February 12, 1997.
1 This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture, Japan.
Send reprint requests to: Dr. T. Iijima, Department of Pharmacology, Akita University School of Medicine, 1-1-1 Hondoh, Akita 010, Japan.
| |
Abbreviations |
|---|
KATP channels, ATP-sensitive
K+ channel;
KRN4884, 5-amino-N-[2-(2-chlorophenylethyl]-N
-cyano-3-pyridinecarboxamidine;
NDP, nucleoside diphosphate;
UDP, uridine 5
-diphosphate;
DMSO, dimethyl sulfoxide;
EGTA, ethyleneglycol-bis(
-aminoethyl
ether)-N,N,N
,N
-tetraacetic acid;
HEPES, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid.
| |
References |
|---|
|
|
|---|
-cell high-affinity sulfonylurea receptor: A regulator of insulin secretion.
Science
268: 423-426, 1995.
-cells.
Nature
311: 271-273, 1984.
cells.
Proc. Natl. Acad. Sci. U.S.A.
83: 7119-7123, 1986.
-triphosphate-regulated potassium channels of frog skeletal muscle.
J. Physiol.
382: 213-236, 1987.This article has been cited by other articles:
![]() |
Z. Ren, Q. Yang, H. Storm Floten, and G.-W. He Hypoxic preconditioning in coronary microarteries: role of EDHF and K+ channel openers Ann. Thorac. Surg., July 1, 2002; 74(1): 143 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ren, Q. Yang, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He ATP-sensitive potassium channel openers may mimic the effects of hypoxic preconditioning on the coronary artery Ann. Thorac. Surg., February 1, 2001; 71(2): 642 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baron, L. van Bever, D. Monnier, A. Roatti, and A. J. Baertschi A Novel KATP Current in Cultured Neonatal Rat Atrial Appendage Cardiomyocytes Circ. Res., October 15, 1999; 85(8): 707 - 715. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||